Takao Kohno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Takao Kohno has a total of 285 co-authors. Here are the top co-authors by number of shared publications:
- Mitsuharu Hattori
Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University
32 shared publications - Atsushi Baba
Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Japan
6 shared publications Yoshimi Nakano
Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Aichi 467-8603, Japan, and
6 shared publicationsKeisuke Ishii
Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University
5 shared publicationsMitsuharu Hattori
Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University
4 shared publicationsArisa Hisanaga
Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi 467-8603, Japan
3 shared publications
Latest Publications
- 24 August 2026
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 46 (37)
Myosin Va Regulates Terminal Translocation in the Neocortex by Controlling the Trafficking of Neuropilin-1
Proper neocortex formation relies on the precisely regulated migration of neurons into distinct cortical layers. This process requires the timely surface expression of receptors that decode extracellular guidance cues. Yet, the molecular machinery governing receptor trafficking in migrating neurons remains largely unclear. Here, we identified the motor protein myosin Va (Myo5a) as a key regulator of Neuropilin-1 (Nrp1) trafficking in the early postnatal neocortex. Both male and female mice were used for this study. Myo5a localized to the apical dendrites of superficial layer neurons, with expression increasing during cortical maturation. Functional inhibition of Myo5a led to a terminal translocation defect in superficial layer neurons, thereby preventing their proper entry into NeuN-negative regions of the neocortex. Additionally, Myo5a inhibition led to Nrp1 accumulation within the Golgi apparatus and a significant reduction in its surface expression. Remarkably, overexpression of Nrp1 or VLDLR fully rescued the terminal translocation defects and dendritic abnormalities caused by Myo5a inhibition, demonstrating that Myo5a-dependent Nrp1 trafficking underlies proper Reelin receptor availability during this process. Overall, these results reveal a pivotal Myo5a–Nrp1 trafficking pathway that governs the final stage of neuronal migration, offering a molecular mechanism for the spatial and temporal regulation of receptor dynamics essential for precise cortical layering.
- 24 August 2026
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 46 (37)
Myosin Va Regulates Terminal Translocation in the Neocortex by Controlling the Trafficking of Neuropilin-1
Proper neocortex formation relies on the precisely regulated migration of neurons into distinct cortical layers. This process requires the timely surface expression of receptors that decode extracellular guidance cues. Yet, the molecular machinery governing receptor trafficking in migrating neurons remains largely unclear. Here, we identified the motor protein myosin Va (Myo5a) as a key regulator of Neuropilin-1 (Nrp1) trafficking in the early postnatal neocortex. Both male and female mice were used for this study. Myo5a localized to the apical dendrites of superficial layer neurons, with expression increasing during cortical maturation. Functional inhibition of Myo5a led to a terminal translocation defect in superficial layer neurons, thereby preventing their proper entry into NeuN-negative regions of the neocortex. Additionally, Myo5a inhibition led to Nrp1 accumulation within the Golgi apparatus and a significant reduction in its surface expression. Remarkably, overexpression of Nrp1 or VLDLR fully rescued the terminal translocation defects and dendritic abnormalities caused by Myo5a inhibition, demonstrating that Myo5a-dependent Nrp1 trafficking underlies proper Reelin receptor availability during this process. Overall, these results reveal a pivotal Myo5a–Nrp1 trafficking pathway that governs the final stage of neuronal migration, offering a molecular mechanism for the spatial and temporal regulation of receptor dynamics essential for precise cortical layering.
- Open Access
- 3 September 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (9) , e70225
Reelin Increases the Sphingomyelin Content of the Plasma Membrane and Affects the Surface Expression of GPI ‐Anchored Proteins in Hippocampal Neurons
Sphingomyelin (SM) is primarily located in the outer leaflet of the plasma membrane. It plays a crucial role in intercellular communication and the morphology of neuronal cells by influencing the localization and function of various proteins. However, the mechanisms regulating the SM content in the neuronal plasma membrane remain largely elusive. In this study, we discovered that Reelin, an important secreted signaling protein in the central nervous system, increases the SM content of the plasma membrane of cultured hippocampal neurons by promoting SM synthesis using a SM specific probe and a fluorescently labeled SM precursor molecule. This increase in SM was associated with increased surface expression of glycosylphosphatidylinositol (GPI)‐anchored proteins analyzed by immunohistochemistry or using phosphatidylinositol‐specific phospholipase C, suggesting a functional link between SM levels and membrane protein trafficking. Furthermore, comparative lipidomic analysis of the postsynaptic density fraction by LC–MS/MS revealed distinct alterations in SM‐related lipid species between wild‐type and Reelin‐deficient mice. These findings suggest that Reelin regulates the SM content in the neuronal plasma membrane, which, in turn, affects the function and morphology of the neuron by affecting the surface levels of GPI‐anchored proteins. These findings identify a novel role for Reelin in modulating neuronal membrane lipid composition, which may underlie its diverse functions in neuronal development and synaptic plasticity in both the developing and adult brain. image
- 3 September 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (9) , e70225
Open AccessReelin Increases the Sphingomyelin Content of the Plasma Membrane and Affects the Surface Expression of GPI ‐Anchored Proteins in Hippocampal Neurons
Sphingomyelin (SM) is primarily located in the outer leaflet of the plasma membrane. It plays a crucial role in intercellular communication and the morphology of neuronal cells by influencing the localization and function of various proteins. However, the mechanisms regulating the SM content in the neuronal plasma membrane remain largely elusive. In this study, we discovered that Reelin, an important secreted signaling protein in the central nervous system, increases the SM content of the plasma membrane of cultured hippocampal neurons by promoting SM synthesis using a SM specific probe and a fluorescently labeled SM precursor molecule. This increase in SM was associated with increased surface expression of glycosylphosphatidylinositol (GPI)‐anchored proteins analyzed by immunohistochemistry or using phosphatidylinositol‐specific phospholipase C, suggesting a functional link between SM levels and membrane protein trafficking. Furthermore, comparative lipidomic analysis of the postsynaptic density fraction by LC–MS/MS revealed distinct alterations in SM‐related lipid species between wild‐type and Reelin‐deficient mice. These findings suggest that Reelin regulates the SM content in the neuronal plasma membrane, which, in turn, affects the function and morphology of the neuron by affecting the surface levels of GPI‐anchored proteins. These findings identify a novel role for Reelin in modulating neuronal membrane lipid composition, which may underlie its diverse functions in neuronal development and synaptic plasticity in both the developing and adult brain. image
- 21 August 2024
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 176 (5) , 385-393
Biochemical characterizations of the central fragment of human Reelin and identification of amino acid residues involved in its secretion
Secreted protein Reelin is implicated in neuropsychiatric disorders and its supplementation ameliorates neurological symptoms in mouse disease models. Recombinant human Reelin protein may be useful for the treatment of human diseases, but its properties remain uncharacterized. Here, we report that full-length human Reelin was well secreted from transfected cells and was able to induce Dab1 phosphorylation. Unexpectedly, the central fragment of human Reelin was much less secreted than that of mouse Reelin. Three residues in the sixth Reelin repeat contributed to the secretion inefficiency, and their substitutions with mouse residues increased the secretion without affecting its biological activity. Our findings help efficient production of human Reelin protein for the supplementation therapy.
- 21 August 2024
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 176 (5) , 385-393
Biochemical characterizations of the central fragment of human Reelin and identification of amino acid residues involved in its secretion
Secreted protein Reelin is implicated in neuropsychiatric disorders and its supplementation ameliorates neurological symptoms in mouse disease models. Recombinant human Reelin protein may be useful for the treatment of human diseases, but its properties remain uncharacterized. Here, we report that full-length human Reelin was well secreted from transfected cells and was able to induce Dab1 phosphorylation. Unexpectedly, the central fragment of human Reelin was much less secreted than that of mouse Reelin. Three residues in the sixth Reelin repeat contributed to the secretion inefficiency, and their substitutions with mouse residues increased the secretion without affecting its biological activity. Our findings help efficient production of human Reelin protein for the supplementation therapy.
- Open Access
- 18 July 2024
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 47 (7) , 1314-1320
EphA4 Induces the Phosphorylation of an Intracellular Adaptor Protein Dab1 via Src Family Kinases
Dab1 is an intracellular adaptor protein essential for brain formation during development. Tyrosine phosphorylation in Dab1 plays important roles in neuronal migration, dendrite development, and synapse formation by affecting several downstream pathways. Reelin is the best-known extracellular protein that induces Dab1 phosphorylation. However, whether other upstream molecule(s) contribute to Dab1 phosphorylation remains largely unknown. Here, we found that EphA4, a member of the Eph family of receptor-type tyrosine kinases, induced Dab1 phosphorylation when co-expressed in cultured cells. Tyrosine residues phosphorylated by EphA4 were the same as those phosphorylated by Reelin in neurons. The autophosphorylation of EphA4 was necessary for Dab1 phosphorylation. We also found that EphA4-induced Dab1 phosphorylation was mediated by the activation of the Src family tyrosine kinases. Interestingly, Dab1 phosphorylation was not observed when EphA4 was activated by ephrin-A5 in cultured cortical neurons, suggesting that Dab1 is localized in a different compartment in them. EphA4-induced Dab1 phosphorylation may occur under limited and/or pathological conditions in the brain.
- 18 July 2024
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 47 (7) , 1314-1320
Open AccessEphA4 Induces the Phosphorylation of an Intracellular Adaptor Protein Dab1 via Src Family Kinases
Dab1 is an intracellular adaptor protein essential for brain formation during development. Tyrosine phosphorylation in Dab1 plays important roles in neuronal migration, dendrite development, and synapse formation by affecting several downstream pathways. Reelin is the best-known extracellular protein that induces Dab1 phosphorylation. However, whether other upstream molecule(s) contribute to Dab1 phosphorylation remains largely unknown. Here, we found that EphA4, a member of the Eph family of receptor-type tyrosine kinases, induced Dab1 phosphorylation when co-expressed in cultured cells. Tyrosine residues phosphorylated by EphA4 were the same as those phosphorylated by Reelin in neurons. The autophosphorylation of EphA4 was necessary for Dab1 phosphorylation. We also found that EphA4-induced Dab1 phosphorylation was mediated by the activation of the Src family tyrosine kinases. Interestingly, Dab1 phosphorylation was not observed when EphA4 was activated by ephrin-A5 in cultured cortical neurons, suggesting that Dab1 is localized in a different compartment in them. EphA4-induced Dab1 phosphorylation may occur under limited and/or pathological conditions in the brain.
- Open Access
- 26 March 2024
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment
Increased levels of lactate, an end-product of glycolysis, have been proposed as a potential surrogate marker for metabolic changes during neuronal excitation. These changes in lactate levels can result in decreased brain pH, which has been implicated in patients with various neuropsychiatric disorders. We previously demonstrated that such alterations are commonly observed in five mouse models of schizophrenia, bipolar disorder, and autism, suggesting a shared endophenotype among these disorders rather than mere artifacts due to medications or agonal state. However, there is still limited research on this phenomenon in animal models, leaving its generality across other disease animal models uncertain. Moreover, the association between changes in brain lactate levels and specific behavioral abnormalities remains unclear. To address these gaps, the International Brain pH Project Consortium investigated brain pH and lactate levels in 109 strains/conditions of 2294 animals with genetic and other experimental manipulations relevant to neuropsychiatric disorders. Systematic analysis revealed that decreased brain pH and increased lactate levels were common features observed in multiple models of depression, epilepsy, Alzheimer’s disease, and some additional schizophrenia models. While certain autism models also exhibited decreased pH and increased lactate levels, others showed the opposite pattern, potentially reflecting subpopulations within the autism spectrum. Furthermore, utilizing large-scale behavioral test battery, a multivariate cross-validated prediction analysis demonstrated that poor working memory performance was predominantly associated with increased brain lactate levels. Importantly, this association was confirmed in an independent cohort of animal models. Collectively, these findings suggest that altered brain pH and lactate levels, which could be attributed to dysregulated excitation/inhibition balance, may serve as transdiagnostic endophenotypes of debilitating neuropsychiatric disorders characterized by cognitive impairment, irrespective of their beneficial or detrimental nature.
- 26 March 2024
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Open AccessLarge-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment
Increased levels of lactate, an end-product of glycolysis, have been proposed as a potential surrogate marker for metabolic changes during neuronal excitation. These changes in lactate levels can result in decreased brain pH, which has been implicated in patients with various neuropsychiatric disorders. We previously demonstrated that such alterations are commonly observed in five mouse models of schizophrenia, bipolar disorder, and autism, suggesting a shared endophenotype among these disorders rather than mere artifacts due to medications or agonal state. However, there is still limited research on this phenomenon in animal models, leaving its generality across other disease animal models uncertain. Moreover, the association between changes in brain lactate levels and specific behavioral abnormalities remains unclear. To address these gaps, the International Brain pH Project Consortium investigated brain pH and lactate levels in 109 strains/conditions of 2294 animals with genetic and other experimental manipulations relevant to neuropsychiatric disorders. Systematic analysis revealed that decreased brain pH and increased lactate levels were common features observed in multiple models of depression, epilepsy, Alzheimer’s disease, and some additional schizophrenia models. While certain autism models also exhibited decreased pH and increased lactate levels, others showed the opposite pattern, potentially reflecting subpopulations within the autism spectrum. Furthermore, utilizing large-scale behavioral test battery, a multivariate cross-validated prediction analysis demonstrated that poor working memory performance was predominantly associated with increased brain lactate levels. Importantly, this association was confirmed in an independent cohort of animal models. Collectively, these findings suggest that altered brain pH and lactate levels, which could be attributed to dysregulated excitation/inhibition balance, may serve as transdiagnostic endophenotypes of debilitating neuropsychiatric disorders characterized by cognitive impairment, irrespective of their beneficial or detrimental nature.
- Open Access
- 28 December 2023
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 12
Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment
Increased levels of lactate, an end-product of glycolysis, have been proposed as a potential surrogate marker for metabolic changes during neuronal excitation. These changes in lactate levels can result in decreased brain pH, which has been implicated in patients with various neuropsychiatric disorders. We previously demonstrated that such alterations are commonly observed in five mouse models of schizophrenia, bipolar disorder, and autism, suggesting a shared endophenotype among these disorders rather than mere artifacts due to medications or agonal state. However, there is still limited research on this phenomenon in animal models, leaving its generality across other disease animal models uncertain. Moreover, the association between changes in brain lactate levels and specific behavioral abnormalities remains unclear. To address these gaps, the International Brain pH Project Consortium investigated brain pH and lactate levels in 109 strains/conditions of 2,294 animals with genetic and other experimental manipulations relevant to neuropsychiatric disorders. Systematic analysis revealed that decreased brain pH and increased lactate levels were common features observed in multiple models of depression, epilepsy, Alzheimer’s disease, and some additional schizophrenia models. While certain autism models also exhibited decreased pH and increased lactate levels, others showed the opposite pattern, potentially reflecting subpopulations within the autism spectrum. Furthermore, utilizing large-scale behavioral test battery, a multivariate cross-validated prediction analysis demonstrated that poor working memory performance was predominantly associated with increased brain lactate levels. Importantly, this association was confirmed in an independent cohort of animal models. Collectively, these findings suggest that altered brain pH and lactate levels, which could be attributed to dysregulated excitation/inhibition balance, may serve as transdiagnostic endophenotypes of debilitating neuropsychiatric disorders characterized by cognitive impairment, irrespective of their beneficial or detrimental nature.
- 28 December 2023
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 12
Open AccessLarge-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment
Increased levels of lactate, an end-product of glycolysis, have been proposed as a potential surrogate marker for metabolic changes during neuronal excitation. These changes in lactate levels can result in decreased brain pH, which has been implicated in patients with various neuropsychiatric disorders. We previously demonstrated that such alterations are commonly observed in five mouse models of schizophrenia, bipolar disorder, and autism, suggesting a shared endophenotype among these disorders rather than mere artifacts due to medications or agonal state. However, there is still limited research on this phenomenon in animal models, leaving its generality across other disease animal models uncertain. Moreover, the association between changes in brain lactate levels and specific behavioral abnormalities remains unclear. To address these gaps, the International Brain pH Project Consortium investigated brain pH and lactate levels in 109 strains/conditions of 2,294 animals with genetic and other experimental manipulations relevant to neuropsychiatric disorders. Systematic analysis revealed that decreased brain pH and increased lactate levels were common features observed in multiple models of depression, epilepsy, Alzheimer’s disease, and some additional schizophrenia models. While certain autism models also exhibited decreased pH and increased lactate levels, others showed the opposite pattern, potentially reflecting subpopulations within the autism spectrum. Furthermore, utilizing large-scale behavioral test battery, a multivariate cross-validated prediction analysis demonstrated that poor working memory performance was predominantly associated with increased brain lactate levels. Importantly, this association was confirmed in an independent cohort of animal models. Collectively, these findings suggest that altered brain pH and lactate levels, which could be attributed to dysregulated excitation/inhibition balance, may serve as transdiagnostic endophenotypes of debilitating neuropsychiatric disorders characterized by cognitive impairment, irrespective of their beneficial or detrimental nature.
- 1 April 2023
- Published by Elsevier in Neuroscience Research
- Vol. 194, 7-14
Postnatal injection of Reelin protein into the cerebellum ameliorates the motor functions in reeler mouse
- 1 April 2023
- Published by Elsevier in Neuroscience Research
- Vol. 194, 7-14
Postnatal injection of Reelin protein into the cerebellum ameliorates the motor functions in reeler mouse
- 24 November 2022
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 124, 103794
Reelin regulates the migration of late-born hippocampal CA1 neurons via cofilin phosphorylation
- 24 November 2022
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 124, 103794
Reelin regulates the migration of late-born hippocampal CA1 neurons via cofilin phosphorylation
- Open Access
- 1 November 2021
- Published by Elsevier in Pharmacological Research
- Vol. 173, 105832
Microinjection of Reelin into the mPFC prevents MK-801-induced recognition memory impairment in mice
- 1 November 2021
- Published by Elsevier in Pharmacological Research
- Vol. 173, 105832
Open AccessMicroinjection of Reelin into the mPFC prevents MK-801-induced recognition memory impairment in mice
- 1 March 2021
- Published by Elsevier in Neurochemistry International
- Vol. 144, 104954
Analysis of Reelin signaling and neurodevelopmental trajectory in primary cultured cortical neurons with RELN deletion identified in schizophrenia
- 1 March 2021
- Published by Elsevier in Neurochemistry International
- Vol. 144, 104954
Analysis of Reelin signaling and neurodevelopmental trajectory in primary cultured cortical neurons with RELN deletion identified in schizophrenia